A study of the mental health status of Chinese medical students at risk of COVID-19 infection

Year & Volume - Issue: 
Authors: 
Leyi Fang
Heading: 
Article type: 
CID: 
e0105
PDF File: 
Abstract: 
Background — The COVID-19 pandemic and subsequent changes in health policies may have impacted the mental health of medical students in China. Objective — This study aimed to assess the mental health status of Chinese medical students after adjustments to the country’s pandemic response measures. Methods — We conducted a cross-sectional online survey of 872 medical students using several standardized instruments: 7-item Generalized Anxiety Disorder (GAD-7), 9-item Patient Health Questionnaire (PHQ-9), 10-item Connor-Davidson Resilience Scale (CD-RISC-10), the Impact of Events Scale-Revised (IES-R), and the Simplified Coping Styles Questionnaire (SCSQ). Results — The survey revealed that 25.0% of participants had anxiety symptoms, 35.7% had symptoms of depression, and 22.13% had post-traumatic stress disorder (PTSD). Significant influencing factors included education level, history of close contact with COVID-19 patients, personal history of infection, and physical health status (p<0.05). Multivariate logistic regression revealed that individuals with a history of COVID-19 were more likely to report mild anxiety; higher education was associated with moderate to severe anxiety, as well as mild, moderate, and severe depression; individuals with chronic medical conditions were more likely to report anxiety, depression, and PTSD (all statistically significant associations p<0.05). Conclusion — Following policy adjustments in the context of the pandemic, medical students experienced significant mental health problems, such as anxiety, depression, and PTSD. Support efforts should involve upper-year students and students with chronic diseases, and should focus on strengthening resilience and positive coping skills.
Cite as: 
Fang L. A study of the mental health status of Chinese medical students at risk of COVID-19 infection. Russian Open Medical Journal 2026; 15: e0105.
DOI: 
10.15275/rusomj.2026.0105

Introduction

Since the outbreak of the novel coronavirus disease (COVID-19) late in 2019, global socioeconomic stability and mental health of the public have faced unprecedented challenges. According to the World Health Organization (WHO), the number of new cases of major depressive disorder and anxiety disorders worldwide in 2020 reached 53 million and 76 million, respectively, representing a 25% increase compared with pre-pandemic levels [1]. As the virus evolved and herd immunity changed, many countries and regions gradually adjusted their pandemic control strategies. On December 7, 2022, the Chinese government announced 10 new measures to optimize its prevention and control policies. Following these adjustments, infection rates increased sharply in the short term [2] significantly impacting the mental health of the population. Research shows that during this period, the prevalence of anxiety and depressive symptoms among the Chinese population reached 30.1% and 55.7%, respectively [3].

Medical students, as future healthcare professionals, represent a critical population whose mental health requires close attention during the pandemic. Research shows that medical students often face heavy academic workloads, intense competition, and career-related anxiety, making them particularly vulnerable to mental health problems [4]. A study by Saraswati et al. in India [5] found that during the pandemic, medical students experienced elevated levels of anxiety and stress due to disruptions in education process and increased risk of infection. Chinese medical students experienced similar problems [6]. The increased risk of infection may have exacerbated preexisting mental health problems.

However, research on medical student mental health after the lifting of pandemic restrictions remains limited. Some scholars suggest that easing restrictions may help reduce negative emotions caused by prolonged isolation [3]. Yet medical students, due to the demands of their studies and future work environments, are at higher risk of infection and exposure to viruses. As a result, their mental health may evolve differently than that of the general population. Therefore, this study aims to assess the mental health of Chinese medical students during the early stages of policy relaxation, which will serve as a basis for further research.

 

Material and Methods

Study Design

This cross-sectional study was conducted on a random sample of medical students at Huzhou university, Huzhou, Zhejiang Province, China. Data collection was performed from December 2022 through January 2023, in accordance with China’s pandemic policy adjustments. The study protocol was approved by the Ethics Committee of Huzhou University (approval number 202302-02), and all study participants were volunteers.

 

Sampling procedure and participant selection

This study used simple random sampling in accordance with epidemiological survey protocol. Participants were selected from 1,676 students majoring in Nursing, Oral Medicine, and Clinical Medicine at the College of Medicine during the 2022–2023 academic year. Inclusion criteria were current enrollment and voluntary participation with electronic informed consent. A diagnosed mental disorder was an exclusion criterion. Based on the college’s electronic medical records, 15 students who met the exclusion criterion were excluded, leaving 1,661 eligible participants.

The administration provided an anonymized list containing only serial numbers, gender, and education level information. Using the RAND() function in Microsoft Excel 2019, the research team randomly selected 1,112 serial numbers (67.0% of the sample) and returned them to the administration, which then distributed survey invitations through the university’s official communication platform, WeChat. The research team did not have access to any of the students’ personal data or contact information.

An anonymous online survey was administered using Wenjuanxing (https://www.wjx.cn), and participants were required to complete all items before submitting. To increase response rates, the administration sent two reminder messages, one week apart, to non-respondents. A total of 896 students completed the survey (a response rate of 80.6%). After quality control for completion time and the availability of response templates, 872 valid questionnaires (97.3% validity rate) were retained. Although two reminder emails were sent to increase participation, no additional follow-up was conducted to avoid coercion. The total number of non-responders (n=216) was recorded but individual demographic data were anonymized. To assess representativeness, aggregated data (gender and education level) were compared between invited and responding students (see Supplementary Table S1). The results showed no significant differences, thereby indicating minimum non-response bias.

 

Questionnaire

The questionnaire consisted of two main sections.

Based on established methodologies from similar studies [7,8], the first section collected sociodemographic data relevant to mental health during and after the pandemic. These included gender, age, education level, place of residence, occupation, self-assessed physical health, daily time spent on pandemic-related news, history of close contact with COVID-19 patients, and personal or family history of COVID-19 infection.

The second section assessed mental health outcomes using validated instruments measuring resilience, anxiety, depression, post-traumatic stress disorder (PTSD), and coping strategies. The following scales were used:

(1) Resilience was assessed using the 10-item version of the Connor-Davidson Resilience Scale (CD-RISC-10) [9]. This instrument includes 10 items; each item is scored on a five-point scale ranging from 0 (not at all) to 4 (almost always).

(2) Anxiety symptoms were assessed using the General Anxiety Disorder-7 (GAD-7) [10], with scores ranging from 0 to 21, where higher scores indicate greater severity.

(3) Depression symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) [11] with scores ranging from 0 to 27.

(4) PTSD was assessed using the Impact of Event Scale-Revised (IES-R) [12], a widely used 22-item self-report instrument assessing three clusters: intrusion (obsessive thoughts), hyperarousal, and avoidance. Items are rated on a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely).

(5) Coping skills were assessed using the 20-item Simplified Coping Style Questionnaire (SCSQ) [13]. The SCSQ includes two subscales: positive coping strategies (12 items) and negative coping strategies (8 items) rated on a 4-point Likert scale (0=not at all, 3=usually).

The results were interpreted as follows: (1) GAD-7: ≤4 (normal), 5-9 (mild), ≥10 (moderate to severe) anxiety [14]; (2) PHQ-9: ≤4 (normal), 5-9 (mild), ≥10 (moderate to severe) depression [15]; (3) IES-R: ≤23 (normal), 24-32 (mild), ≥33 (moderate to severe) PTSD [16].

The two-section structure of the questionnaire was strictly adhered to for all participants: demographic data were administered in a fixed order and validated scales were administered sequentially. No variations or conditional branching were implemented.

Statistical data processing

Categorical data were described using frequencies (%), and univariate analysis was conducted using the chi-squared test and Fisher’s exact test. Based on the univariate analysis results, statistically significant variables were included in multivariate logistic regression models to identify sociodemographic and health-related factors associated with different levels of anxiety, depression, and PTSD symptoms (normal, mild, and above moderate). One-way analysis of variance (ANOVA) was employed to compare differences in resilience and positive/negative coping strategies among individuals with different levels of anxiety, depression, and PTSD symptoms. Tukey’s post hoc test was performed for statistically significant results. Statistical data processing used R 4.4.1 software, while graphs were created using GraphPad Prism 9.0. A p-value of <0.05 was considered statistically significant.

 

Sociodemographic characteristics of the study participants

The study included 872 medical students with a mean age of 19.26 years (SD=1.47). Of these, 590 (67.7%) were women and 282 (32.3%) were men. The participants were enrolled in three academic majors: Clinical Medicine (419 students, 48.0%), Nursing (321 students, 36.8%), and Oral Medicine (132 students, 15.1%). Most participants were first-year medical students (63.0%) and reported good health (95.5%). Detailed characteristics are presented in Table 1.

 

Table 1. Sociodemographic parameters of the study participants

Variables

 

 

Continuous variables

Mean±SD

Age, years

 

19.26±1.47

Completion time, min

 

4.99±3.66

Categorical variables

N

%

Gender

Male

282

32.3

Female

590

67.7

Place of residence

Urban

439

50.3

Rural

433

49.7

Education level

Freshman

550

63.0

Sophomore

185

21.2

Upper-year

137

15.8

Major

Clinical Medicine

419

48.0

Oral Medicine

132

15.1

Nursing

321

36.8

Daily time dedicated to COVID-19, h

<=1

348

39.9

1~3

382

43.8

>=3

142

16.3

Health status

Healthy

833

95.5

Unhealthy

39

4.5

History of close contact with COVID-19 patients

No

219

25.1

Yes

653

74.9

Personal history of COVID-19 infection

No

335

38.4

Yes

537

61.6

History of COVID-19 infection in the household

No

156

17.9

Yes

716

82.1

 

Results

Anxiety levels among medical students

Univariate analysis revealed that freshmen (22.18% vs. 28.11%/32.11%), those without a history of COVID-19 (20.00% vs. 28.12%), and those in good health (24.01% vs. 46.15%) had lower rates of anxiety symptoms (shown in Table S2, Figure S1A). Multivariate logistic regression analysis (Table 2) showed that a history of infection (OR=1.532, 95% CI [1.087-2.160], p=0.015) and poor health status (OR=2.168, 95% CI [1.075-4.374], p=0.031) were statistically significantly associated with higher rates of mild anxiety symptoms. In contrast, higher education level was significantly linked with higher levels of above-moderate anxiety (OR=1.700, 95% CI [1.021-2.831], p=0.041), while poor health increased the risk of above-moderate anxiety as well (OR=5.871, 95% CI [1.804-19.106], p=0.003).

 

Table 2. Results of the multivariate logistic regression model for anxiety levels

 

β

S.D.

z

Wald χ2

p

OR

95% CI

Mild

Education level

0.196

0.106

1.841

3.388

0.066

1.216

0.987~1.498

Personal history of COVID-19 infection

0.426

0.175

2.434

5.924

0.015

1.532

1.087~2.160

Health status

0.774

0.358

2.161

4.672

0.031

2.168

1.075~4.374

Intercept

-1.821

0.217

-8.404

70.626

0.000

0.162

0.106~0.248

Above moderate

Education level

0.530

0.260

2.039

4.156

0.041

1.700

1.021~2.831

Personal history of COVID-19 infection

0.326

0.469

0.695

0.483

0.487

1.385

0.552~3.475

Health Status

1.770

0.602

2.940

8.644

0.003

5.871

1.804~19.106

Intercept

-4.639

0.610

-7.605

57.835

0.000

0.010

0.003~0.032

Reference category: normal level of symptoms.

 

Depression levels among medical students

Univariate analysis revealed that medical students exhibited lower rates of depressive symptoms if they were freshmen (31.45% vs. 41.62%/44.53%), had no close contacts with COVID-19 patients (28.31% vs. 38.13%), had no history of COVID-19 infection (29.25% vs. 39.66%), and exhibited good physical health (34.21% vs. 66.66%) (Table S3 and Figure S1B). The multivariate model (Table 3) showed that higher education level was significantly associated with mild depression (OR=1.282, 95% CI [1.053-1.559], p=0.013) and above-moderate depression (OR=1.438, 95% CI [1.016–2.035], p=0.040). History of infection was associated with mild depression (OR=1.438, 95% CI [1.005-2.058], p=0.047). Poor health was independently associated with both mild depression (OR=2.730, 95% CI [1.295-5.756], p=0.008) and above-moderate depression (OR=7.223, 95% CI [2.895-18.021], p<0.001). In contrast, close contacts were not statistically significantly associated with either mild or above-moderate depressive symptoms (all p>0.05).

 

Table 3. Results of the multivariate logistic regression model for depression levels

 

β

S.D.

z

Wald χ2

p

OR

95% CI

Mild

Education level

0.248

0.100

2.480

6.152

0.013

1.282

1.053~1.559

History of close contact with COVID-19 patients

0.182

0.209

0.870

0.756

0.385

1.200

0.796~1.808

Personal history of COVID-19 infection

0.363

0.183

1.989

3.956

0.047

1.438

1.005~2.058

Health status

1.004

0.381

2.639

6.962

0.008

2.730

1.295~5.756

Intercept

-1.581

0.224

-7.073

50.028

0.000

0.206

0.133~0.319

Above moderate

Education level

0.363

0.177

2.052

4.209

0.040

1.438

1.016~2.035

History of close contact with COVID-19 patients

0.131

0.404

0.323

0.105

0.746

1.140

0.516~2.515

Personal history of COVID-19 infection

0.324

0.345

0.939

0.881

0.348

1.382

0.703~2.716

Health status

1.977

0.466

4.239

17.969

0.000

7.223

2.895~18.021

Intercept

-3.325

0.429

-7.747

60.018

0.000

0.036

0.016~0.083

Reference category: normal level of symptoms.

 

PTSD prevalence among medical students

Medical students residing in urban areas (19.8% vs. 24.5%), as well as students with good physical health (21.1% vs. 43.6%), demonstrated a lower prevalence of PTSD symptoms (Table S4 and Figure S1C). Multivariate logistic regression analysis (Table 4) revealed that poor health was significantly associated with higher levels of PTSD symptoms. Specifically, it was linked with mild PTSD (OR=2.484, 95% CI [1.070-5.769], p=0.034) and moderate PTSD (OR=3.253, 95% CI [1.448-7.305], p=0.004).

 

Table 4. results of the multivariate logistic regression model for PTSD levels

 

β

S.D.

z

Wald χ2

p

OR

95% CI

Mild

Health Status

0.910

0.430

2.116

4.479

0.034

2.484

1.070~5.769

Residence

0.568

0.220

2.585

6.684

0.010

1.765

1.147~2.716

Intercept

-2.836

0.369

-7.676

58.920

0.000

0.059

0.028~0.121

Above moderate

Health status

1.179

0.413

2.858

8.165

0.004

3.253

1.448~7.305

Residence

-0.073

0.224

-0.326

0.107

0.744

0.930

0.599~1.442

Intercept

-1.961

0.348

-5.641

31.822

0.000

0.141

0.071~0.278

Reference category: normal level of symptoms.

 

Differences in resilience and positive coping strategies across groups with varying levels of anxiety, depression, and PTSD symptom severity

levels of anxiety, depression, and PTSD symptoms (ANOVA results are presented in Tables S5-S7; Tukey’s post hoc test results are presented in Tables S8-S10). The analysis revealed that individuals with normal mental health had significantly higher resilience scores than those in the mild and above-moderate symptom groups across all three mental health indicators (p<0.001). Additionally, the mild symptom group showed significantly higher resilience than the above-moderate symptom group<0.001). Regarding positive coping strategies scores, the normal mental health individuals had significantly higher scores than the above-moderate symptom group (p<0.001). However, no statistically significant differences were observed between the normal group and the group with mild symptoms on measures of anxiety and PTSD.

Figure 1 illustrates the differences in resilience (Figure 1A) and positive coping strategies (Figure 1B) across groups with varying.

 

Figure 1. Distribution of CD-RISC-10 and SCSQ (positive coping strategies) scores according to the level of anxiety, depression, and PTSD. (A) Distribution of CD-RISC-10; (B) Distribution of SCSQ (positive coping strategies).

 

Examining the relationships between mental health factors

To test the hypothesized relationships between mental health constructs, we used structural equation modeling (SEM) (see Supplementary methods section for hypothesis development). The model structure with standardized path coefficients is presented in Figure 2. The model fit the data satisfactorily, as evidenced by the following indices: CFI=0.955, TLI=0.946, SRMR=0.033, RMSEA=0.073. The results confirmed all hypothesized paths: positive coping was a significant positive predictor of resilience (β=0.277, p<0.001) and a significant negative predictor of mood disorders (β=-0.201, p<0.001). Resilience, in turn, was inversely associated with mood disorders (β=-0.523, p<0.001), which were strongly and directly associated with PTSD symptom severity (β=0.790, p<0.001). Descriptive statistics and bivariate correlations for all variables are presented in Table S11.

 

Figure 2. Sequential effects of coping strategies, stress resilience, mood disorders, and posttraumatic stress disorder. ***P<0.001.


Discussion

The impact of pandemic-related policy changes on anxiety, depression, and PTSD symptoms in medical students

This study assessed the mental health of medical students after China’s pandemic policy adjustments. We found lower rates of anxiety (25.0%) and depression (35.7%) compared with both pre-adjustment medical students (29.6%, 52.5%) [17] and the general population after the adjustment (30.1%, 55.7%) [3,6]. We hypothesize that their medical education served as a protective factor. Their expert knowledge potentially facilitated a more scientific interpretation of pandemic information protecting them from widespread psychological stress and promoting better understanding and confidence in national policies, thereby reducing the impact on their mental health.

Our results indicate that students with a high education level demonstrated higher levels of anxiety and depressive symptoms, which is consistent with Shao’s findings [18]. These students are more likely to undergo clinical rotations, where they are often exposed to high-risk healthcare environments. Challenges such as long work hours, sleep deprivation, and limited clinical experience may contribute to elevated stress levels in medical students [19]. In addition to clinical rotations, they also face important career milestones, including taking important national licensing exams, competitive residency placement processes, and beginning a clinical career. Recent studies conducted during the COVID-19 pandemic revealed elevated levels of anxiety in this group due to these career-related challenges [20]. The post-pandemic period, characterized by increased risk of infection, has likely introduced additional uncertainty and anxiety into these already stressful career-defining stages [21]. This is consistent with findings that career-related uncertainty and the pressure of important examinations are significant factors contributing to psychological stress among medical students [22]. However, potential non-response bias should be considered, as students who did not complete the survey may differ in their levels of psychological distress or pandemic experience, which may slightly influence the observed estimates. However, comparison of aggregated demographic data (gender and educational level) between invited and responding students revealed no significant differences, suggesting that the magnitude of such bias was likely negligible. Furthermore, medical students who did not contract COVID-19 reported lower levels of anxiety and depressive symptoms. Numerous studies deminstrated that infected individuals are at a significantly higher risk of developing mental disorders such as anxiety and depression vs. their uninfected peers [23]. Uninfected individuals may have been vaccinated earlier, reducing both the risk of infection and the associated psychological burden [24]. Furthermore, long-term physical consequences of infection, such as fatigue and sleep disorders, may further exacerbate the risk of depression and anxiety [25].

We also established that chronic illnesses were associated with poorer mental health outcomes. Previous research findings suggested that persistent physical discomfort, pain, and functional limitations associated with chronic illnesses may increase vulnerability to anxiety and depression [26, 27]. Conversely, anxiety and depressive symptoms may exacerbate the progression and severity of chronic conditions. Furthermore, prolonged stress associated with managing a chronic illness may lead to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to abnormal secretion of cortisol [28]. This neuroendocrine dysregulation resembles the HPA axis dysfunction observed in patients with PTSD [29], suggesting that HPA axis alterations may serve as a biological pathway linking chronic illness to PTSD symptoms.

 

The protective role of resilience and positive coping strategies

Our results suggest that medical students with higher levels of anxiety, depression, or PTSD symptoms tend to have lower scores on resilience and positive coping strategies. This implies that resilience and positive coping strategies may help protect medical students from psychological stress and support their mental well-being. Resilience is defined as the ability to adapt and recover from adversity or trauma by drawing on internal and external resources [30]. Highly resilient individuals are better able to cope with negative emotions and maintain a positive outlook during challenging times. This allows them to view challenges as opportunities for personal growth while remaining focused and motivated. In contrast, positive coping strategies aim to improve well-being and strengthen social support networks [31]. For medical students, this may include building strong relationships with peers to collaboratively address academic and clinical challenges, thereby creating opportunities for mutual support and encouragement. These social and emotional resources may improve overall well-being and the ability to cope with stress.

Our analysis also revealed that better mental health outcomes were associated with higher resilience and more extensive use of positive coping strategies. These traits may act as protective factors supporting psychological health in challenging environments. This is consistent with previous research [32,33] and highlights the importance of providing mental health support to medical students. In addition to existing counseling and education programs [34], future efforts should include training in resilience skills and positive coping strategies in the medical school curriculum. For senior students and students with chronic illnesses, individualized guidance, such as career planning and self-management support [35,36], may help them prepare for the future and improve overall well-being.

This study has several limitations. First, the sample was drawn from students at a single medical school, and the overrepresentation of female participants may limit the generalizability of the results. Second, a cross-sectional study does not allow for causal inferences. Third, although the administration sent reminder messages to increase participation, non-respondents may have differed from those who responded in their psychological state or level of engagement, potentially biasing the results. Finally, the data were based solely on self-reports without accounting for clinical diagnoses, thereby potentially introducing measurement bias.

 

Conclusion

The study revealed that after China adjusted its pandemic policies, many medical students reported psychological symptoms, including anxiety, depression, and PTSD. Those most affected were senior students, those in close contact with COVID-19 patients, those previously infected, and students with chronic health conditions. Future support efforts should focus on these high-risk groups by providing targeted psychological services, resilience training, and mental health promotion activities tailored to their needs.

 

Conflict of interest

The authors declare no conflicts of interest.

 

Disclosure of generative AI use

Generative artificial intelligence was not used in the preparation of this manuscript.

 

Acknowledgments

The author expresses deep gratitude to Mr. Gu and Ms. Fang for their solid academic support throughout this study. Special thanks are extended to Dr. Shen for his scientific vigilance in providing critical methodological clarifications and intellectual rigor during the editing process.

 

Ethical approval

This study protocol was reviewed and approved by the Biomedical Research Ethics Committee of Huzhou University (202302-02). In accordance with the ethical principles outlined in the Declaration of Helsinki, all participants provided digital informed consent, ensuring their voluntary participation and understanding of the goal and procedures of the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

 

Supplement

Supplementary methods

To facilitate subsequent analyses, we made the following adjustments. First, to assess coping strategies, we standardized scores for both positive and negative coping styles using z-scores. Coping tendency was then determined by calculating the difference between the standardized scores for positive and negative coping styles. A difference greater than 0 indicates a preference for positive coping, while a negative value suggests a preference for negative coping [37]. Second, we categorized symptoms of anxiety and depression as mood disorders [38] to combine these measures. The latent factor of mood disorders was represented by two indicator variables, while PTSD symptoms were represented by three indicator variables.

We employed Mplus 8.0 to construct a structural equation model to examine the relationships between resilience, mood disorders, PTSD symptoms, and coping tendency. Based on previous research [39-43], we proposed the following hypotheses and a theoretical model presented in Figure S2:

H 1: Positive coping positively predicts resilience;

H 2: Positive coping negatively predicts mood disorders;

H 3: Positive coping negatively predicts PTSD symptoms;

H 4: Resilience negatively predicts mood disorders;

H 5: Resilience negatively predicts PTSD symptoms;

H 6: Mood disorders positively predict PTSD symptoms.

 

Table S1. Comparison of invited and responding students in terms of their gender and education level

Variable

Category

Invited

(n=1,112)

Respondents

(n=896)

χ²

p-value

Gender

Male

351

289

0.152

p>0.05

 

Female

761

607

 

Education level

Freshman

649

556

1.713

p>0.05

 

Sophomore

251

189

 
 

Upper-year

212

151

 
We observed no significant differences between invited students and respondents in terms of gender or education level, suggesting minimum non-response bias.

 

Table S2. Univariate analysis of anxiety symptom level among medical students

Variables

Total (n=872)

Normal (n=654)

Mild (n=196)

Above Moderate (n=22)

Statistic

P

Gender

 

 

 

 

χ²=3.60

0.166

Male

282 (32.34)

221 (78.37)

57 (20.21)

4 (1.42)

 

 

Female

590 (67.66)

433 (73.39)

139 (23.56)

18 (3.05)

 

 

Major

 

 

 

 

χ²=3.57

0.467

Clinical medicine

419 (48.05)

316 (75.42)

11 (2.63)

92 (21.96)

 

 

Oral medicine

132 (15.14)

97 (73.48)

6 (4.55)

29 (21.97)

 

 

Nursing

321 (36.81)

241 (75.08)

5 (1.56)

75 (23.36)

 

 

Education level

 

 

 

 

-

0.021

Freshman

550 (63.07)

428 (77.82)

11 (2.00)

111 (20.18)

 

 

Sophomore

185 (21.22)

133 (71.89)

3 (1.62)

49 (26.49)

 

 

Upper-year

137 (15.71)

93 (67.88)

8 (5.84)

36 (26.28)

 

 

Place of residence

 

 

 

 

χ²=5.71

0.058

Urban

439 (50.34)

343 (78.13)

84 (19.13)

12 (2.73)

 

 

Rural

433 (49.66)

311 (71.82)

112 (25.87)

10 (2.31)

 

 

History of close contact with COVID-19 patients

 

 

 

 

χ²=3.41

0.182

No

219 (25.11)

170 (77.63)

47 (21.46)

2 (0.91)

 

 

Yes

653 (74.89)

484 (74.12)

149 (22.82)

20 (3.06)

 

 

Personal history of COVID-19 infection

 

 

 

 

χ²=7.27

0.026

No

335 (38.42)

268 (80.00)

60 (17.91)

7 (2.09)

 

 

Yes

537 (61.58)

386 (71.88)

136 (25.33)

15 (2.79)

 

 

History of COVID-19 infection in the household

 

 

 

 

χ²=2.87

0.238

No

156 (17.89)

121 (77.56)

34 (21.79)

1 (0.64)

 

 

Yes

716 (82.11)

533 (74.44)

162 (22.63)

21 (2.93)

 

 

Health status

 

 

 

 

χ²=15.39

<0.001

Healthy

833 (95.53)

633 (75.99)

182 (21.85)

18 (2.16)

 

 

Unhealthy

39 (4.47)

21 (53.85)

14 (35.90)

4 (10.26)

 

 

Daily timed dedicated to COVID-19, h

 

 

 

 

χ²=5.20

0.268

<=1

348 (39.91)

257 (73.85)

7 (2.01)

84 (24.14)

 

 

1~3

382 (43.81)

289 (75.65)

8 (2.09)

85 (22.25)

 

 

>=3

142 (16.28)

108 (76.06)

7 (4.93)

27 (19.01)

 

 

χ²: Chi-squared test; -: Fisher’s exact test.

 

Table S3. Univariate analysis of depression symptom level among medical students

Variables

Total (n=872)

Normal (n=561)

Mild (n=255)

Above Moderate (n=56)

Statistic

P

Gender

 

 

 

 

χ²=3.17

0.205

Male

282 (32.34)

193 (68.44)

74 (26.24)

15 (5.32)

 

 

Female

590 (67.66)

368 (62.37)

181 (30.68)

41 (6.95)

 

 

Major

 

 

 

 

χ²=1.69

0.792

Clinical medicine

419 (48.05)

276 (65.87)

28 (6.68)

115 (27.45)

 

 

Oral medicine

132 (15.14)

82 (62.12)

7 (5.30)

43 (32.58)

 

 

Nursing

321 (36.81)

203 (63.24)

21 (6.54)

97 (30.22)

 

 

Education level

 

 

 

 

χ²=12.75

0.013

Freshman

550 (63.07)

377 (68.55)

28 (5.09)

145 (26.36)

 

 

Sophomore

185 (21.22)

108 (58.38)

16 (8.65)

61 (32.97)

 

 

Upper-year

137 (15.71)

76 (55.47)

12 (8.76)

49 (35.77)

 

 

Place of residence

 

 

 

 

χ²=5.44

0.066

Urban

439 (50.34)

298 (67.88)

113 (25.74)

28 (6.38)

 

 

Rural

433 (49.66)

263 (60.74)

142 (32.79)

28 (6.47)

 

 

History of close contact with COVID-19 patients

 

 

 

 

χ²=6.90

0.032

No

219 (25.11)

157 (71.69)

51 (23.29)

11 (5.02)

 

 

Yes

653 (74.89)

404 (61.87)

204 (31.24)

45 (6.89)

 

 

Personal history of COVID-19 infection

 

 

 

 

χ²=9.76

0.008

No

335 (38.42)

237 (70.75)

80 (23.88)

18 (5.37)

 

 

Yes

537 (61.58)

324 (60.34)

175 (32.59)

38 (7.08)

 

 

History of COVID-19 infection in the household

 

 

 

 

χ²=5.52

0.063

No

156 (17.89)

113 (72.44)

36 (23.08)

7 (4.49)

 

 

Yes

716 (82.11)

448 (62.57)

219 (30.59)

49 (6.84)

 

 

Health status

 

 

 

 

χ²=26.61

<0.001

Healthy

833 (95.53)

548 (65.79)

238 (28.57)

47 (5.64)

 

 

Unhealthy

39 (4.47)

13 (33.33)

17 (43.59)

9 (23.08)

 

 

Daily timed dedicated to COVID-19, h

 

 

 

 

χ²=5.14

0.273

<=1

348 (39.91)

218 (62.64)

28 (8.05)

102 (29.31)

 

 

1~3

382 (43.81)

246 (64.40)

18 (4.71)

118 (30.89)

 

 

>=3

142 (16.28)

97 (68.31)

10 (7.04)

35 (24.65)

 

 

χ²: Chi-squared test.

 

Table S4. Univariate analysis of PTSD symptom level among medical students

Variables

Total (n=872)

Normal (n=679)

Mild (n=101)

Above Moderate (n=92)

Statistic

P

Gender

 

 

 

 

χ²=2.75

0.253

Male

282 (32.34)

229 (81.21)

27 (9.57)

26 (9.22)

 

 

Female

590 (67.66)

450 (76.27)

74 (12.54)

66 (11.19)

 

 

Major

 

 

 

 

χ²=3.13

0.537

Clinical medicine

419 (48.05)

335 (79.95)

37 (8.83)

47 (11.22)

 

 

Oral medicine

132 (15.14)

102 (77.27)

16 (12.12)

14 (10.61)

 

 

Nursing

321 (36.81)

242 (75.39)

39 (12.15)

40 (12.46)

 

 

Education level

 

 

 

 

χ²=6.93

0.140

Freshman

550 (63.07)

436 (79.27)

48 (8.73)

66 (12.00)

 

 

Sophomore

185 (21.22)

135 (72.97)

28 (15.14)

22 (11.89)

 

 

Upper-year

137 (15.71)

108 (78.83)

16 (11.68)

13 (9.49)

 

 

Place of residence

 

 

 

 

χ²=7.46

0.024

Urban

439 (50.34)

352 (80.18)

38 (8.66)

49 (11.16)

 

 

Rural

433 (49.66)

327 (75.52)

63 (14.55)

43 (9.93)

 

 

History of close contact with COVID-19 patients

 

 

 

 

χ²=1.14

0.566

No

219 (25.11)

175 (79.91)

25 (11.42)

19 (8.68)

 

 

Yes

653 (74.89)

504 (77.18)

76 (11.64)

73 (11.18)

 

 

Personal history of COVID-19 infection

 

 

 

 

χ²=5.97

0.051

No

335 (38.42)

273 (81.49)

37 (11.04)

25 (7.46)

 

 

Yes

537 (61.58)

406 (75.61)

64 (11.92)

67 (12.48)

 

 

History of COVID-19 infection in the household

 

 

 

 

χ²=1.00

0.607

No

156 (17.89)

126 (80.77)

15 (9.62)

15 (9.62)

 

 

Yes

716 (82.11)

553 (77.23)

86 (12.01)

77 (10.75)

 

 

Health status

 

 

 

 

-

0.004

Healthy

833 (95.53)

657 (78.87)

93 (11.16)

83 (9.96)

 

 

Unhealthy

39 (4.47)

22 (56.41)

8 (20.51)

9 (23.08)

 

 

Daily timed dedicated to COVID-19, h

 

 

 

 

χ²=3.31

0.507

<=1

348 (39.91)

278 (79.89)

35 (10.06)

35 (10.06)

 

 

1~3

382 (43.81)

297 (77.75)

41 (10.73)

44 (11.52)

 

 

>=3

142 (16.28)

104 (73.24)

16 (11.27)

22 (15.49)

 

 

χ²: Chi-squared test; -: Fisher’s exact test.

 

Table S5. One-way ANOVA results of CD-RISC-10 and SCSQ scores at different anxiety levels

Sample

Term

df

SUMSQ

MEANSQ

Statistic

P-value

CD-RISC-10

Anxiety level

2

7,049.6151

3,524.80753

91.371

<0.001

Residuals

869

33,523.1877

38.57674

 

 

SCSQ-positive

Anxiety level

2

6,339.7911

3,169.89557

47.542

<0.001

Residuals

869

57,940.7777

66.67523

 

 

SCSQ-negative

Anxiety level

2

127.5478

63.77391

2.027

0.132

Residuals

869

27,343.5336

31.46552

 

 

 

Table S6. One-way ANOVA results of CD-RISC-10 and SCSQ scores at different depression levels

Sample

Term

df

SUMSQ

MEANSQ

Statistic

P-value

CD-RISC-10

Depression level

2

7,262.35206

3,631.176029

94.730

<0.001

Residuals

869

33,310.45069

38.331934

 

 

SCSQ-positive

Depression level

2

7,391.61350

3,695.806752

56.455

<0.001

Residuals

869

56,888.95530

65.464851

 

 

SCSQ-negative

Depression level

2

16.35377

8.176884

0.259

0.772

Residuals

869

27,454.72765

31.593473

 

 

 

Table S7. One-way ANOVA results of CD-RISC-10 and SCSQ scores at different PTSD severity levels

Sample

Term

df

SUMSQ

MEANSQ

Statistic

P-value

CD-RISC-10

PTSD level

2

3,589.28264

1,794.64132

42.169

<0.001

Residuals

869

36,983.52011

42.55871

 

 

SCSQ-positive

PTSD level

2

2,667.68825

1,333.84413

18.813

<0.001

Residuals

869

61,612.88055

70.90090

 

 

SCSQ-negative

PTSD level

2

77.94434

38.97217

1.236

0.291

Residuals

869

27,393.13708

31.52260

 

 

 

Table S8. Tukey’s post-hoc test to compare scores between different groups with different anxiety levels

Comparison

Mean difference

SE of difference

95.00% CI of difference

Adjusted P-value

CD-RISC-10

Normal vs. mild

5.744

0.5058

4.557 to 6.932

<0.0001

Normal vs. above moderate

11.16

1.346

7.998 to 14.32

<0.0001

Mild vs. above moderate

5.414

1.397

2.136 to 8.693

0.0003

SCSQ-positive

Normal vs. mild

5.689

0.6649

4.128 to 7.250

<0.0001

Normal vs. above moderate

9.562

1.77

5.407 to 13.72

<0.0001

Mild vs. above moderate

3.873

1.836

-0.4370 to 8.184

0.0884

 

Table S9. Tukey’s post-hoc test to compare scores between different groups with different depression levels

Comparison

Mean difference

SE of difference

95.00% CI of difference

Adjusted P-value

CD-RISC-10

Normal vs. mild

4.348

0.4676

3.250 to 5.445

<0.0001

Normal vs. above moderate

10.04

0.8677

8.002 to 12.08

<0.0001

Mild vs. above moderate

5.692

0.9137

3.546 to 7.837

<0.0001

SCSQ-positive

Normal vs. mild

4.788

0.6111

3.353 to 6.222

<0.0001

Normal vs. above moderate

9.519

1.134

6.857 to 12.18

<0.0001

Mild vs. above moderate

4.732

1.194

1.929 to 7.535

0.0002

 

Table S10. Tukey’s post-hoc test to compare scores between different groups with different PTSD levels

Comparison

Mean difference

SE of difference

95.00% CI of difference

Adjusted P-value

CD-RISC-10

Normal vs. mild

4.41

0.6957

2.777 to 6.044

<0.0001

Normal vs. above moderate

5.35

0.7248

3.648 to 7.051

<0.0001

Mild vs. above moderate

0.9394

0.9402

-1.268 to 3.147

0.5776

SCSQ-positive

Normal vs. mild

3.299

0.898

1.190 to 5.407

0.0007

Normal vs. above moderate

4.987

0.9355

2.791 to 7.183

<0.0001

Mild vs. above moderate

1.688

1.214

-1.161 to 4.537

0.3459

 

Table S11. Descriptive statistics and correlations between studied variables

 

Mean

SD

1

2

3

4

5

1. Resilience

28.177

6.825

-

 

 

 

 

2. PTSD

13.881

13.730

-0.365**

-

 

 

 

3. Coping strategies

0.456

0.498

0.217**

-0.172**

-

 

 

4. Anxiety

1.287

0.553

-0.394**

0.504**

-0.222**

-

 

5. Depression

1.445

0.696

-0.389**

0.540**

-0.260**

0.582**

-

 

Figure S1. Percentage stacked bar chart of anxiety, depression, and PTSD levels by demographic characteristics among medical students. (A) Anxiety levels; (B) depression levels; (C) PTSD levels. 

 

Figure S2. Proposed structural model of the relationship between coping tendencies, resilience, mood disorders, and PTSD.

References: 
  1. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1260-1344. https://doi.org/10.1016/s0140-6736(17)32130-x.
  2. Chinese Center for Disease Control and Prevention. National COVID-19 Infection Report. November 2024. Chinese https://www.chinacdc.cn/jksj/xgbdyq/202411/t20241112_302573.html.
  3. Tingting Qin, Xingming Li, Mingyu Gu, Yao Wang, Yutong Yang, Xinyuan Bai, et al. Cross-sectional online survey on depression and anxiety among the population infected or non-infected with COVID-19 – China, December 2022. China CDC Weekly 2023; 5(11): 235-240. https://doi.org/10.46234/ccdcw2023.043.
  4. Dyrbye LN, West CP, Satele D, Boone S, Tan L, Sloan J, et al. Burnout among U.S. medical students, residents, and early career physicians relative to the general U.S. population. Acad Med 2014; 89(3): 443-451. https://doi.org/10.1097/ACM.0000000000000134.
  5. Saraswathi I, Saikarthik J, Senthil Kumar K, Madhan Srinivasan K, Ardhanaari M, Gunapriya R. Impact of COVID-19 outbreak on the mental health status of undergraduate medical students in a COVID-19 treating medical college: A prospective longitudinal study. PeerJ 2020; 8: e10164. https://doi.org/10.7717/peerj.10164.
  6. Guo Y, Li S, Zhang L, Xuan Q, He L, Ye Q, et al. Depression and anxiety of medical students at Kunming Medical University during COVID-19: A cross-sectional survey. Front Public Health 2022; 10: 957597. https://doi.org/10.3389/fpubh.2022.957597.
  7. Cheng J, Liao M, He Z, Xiong R, Ju Y, Liu J, et al. Mental health and cognitive function among medical students after the COVID-19 pandemic in China. Front Public Health 2023; 11: 1233975. https://doi.org/10.3389/fpubh.2023.1233975.
  8. Zhang S, Liu Q, Yang F, Zhang J, Fu Y, Zhu Z, et al. Associations between COVID-19 infection experiences and mental health problems among Chinese adults: A large cross-section study. J Affect Disord 2023; 340: 719-727. https://doi.org/10.1016/j.jad.2023.08.080.
  9. Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress 2007; 20(6): 1019-1028. https://doi.org/10.1002/jts.20271.
  10. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166(10): 1092-1097. https://doi.org/10.1001/archinte.166.10.1092.
  11. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16(9): 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.
  12. Beck JG, Grant DM, Read JP, Clapp JD, Coffey SF, Miller LM, et al. The impact of event scale-revised: Psychometric properties in a sample of motor vehicle accident survivors. J Anxiety Disord 2008; 22(2): 187-198. https://doi.org/10.1016/j.janxdis.2007.02.007.
  13. Folkman S, Lazarus RS, Gruen RJ, DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 1986; 50(3): 571-579. https://doi.org/10.1037//0022-3514.50.3.571.
  14. Tao Z, Wu Y, Qiao Y, Wang Z, Chai Y, Wu Q, et al. Somatic symptom disorder in patients with myocardial bridge: Cross-sectional study in China. BJPsych Open 2025; 11(2): e67. https://doi.org/10.1192/bjo.2024.851.
  15. Cheng F, Chen L, Xie H, Wang C, Duan R, Chen D, et al. Influence of parental attitudes and coping styles on mental health during online teaching in the COVID-19 pandemic. Sci Rep 2024; 14(1): 20375. https://doi.org/10.1038/s41598-024-71314-5.
  16. Mathieu A, Reignier J, Le Gouge A, Plantefeve G, Mira JP, Argaud L, et al. Resilience after severe critical illness: a prospective, multicentre, observational study (RESIREA). Crit Care 2024; 28(1): 237. https://doi.org/10.1186/s13054-024-04989-x.
  17. Dan L, Yanping R, Yuqing L, Yu X, Qu W, Wang Z, et al. Psychological status of Chinese residents during COVID-19 outbreak: An online cross-sectional study. Chinese Journal of Psychiatry 2020; 53(3): 181-189. Chinese https://doi.org/10.3760/cma.j.cn113661-20200302-00082.
  18. Shao R, He P, Ling B, Tan L, Xu L, Hou Y, et al. Prevalence of depression and anxiety and correlations between depression, anxiety, family functioning, social support and coping styles among Chinese medical students. BMC Psychol 2020; 8(1): 38. https://doi.org/10.1186/s40359-020-00402-8.
  19. Alhasan AS, Alahmadi SM, Altayeb YA, Daqqaq TS. Impact of long duty hours on education and well-being of diagnostic radiology residents: A national survey in Saudi Arabia. Pak J Med Sci 2022; 38(3Part-I): 570-576. https://doi.org/10.12669/pjms.38.3.4440.
  20. Zheng Q, Lin X, He L, Freudenreich T, Liu T. Impact of the perceived mental stress during the COVID-19 Pandemic on medical students' loneliness feelings and future career choice: A preliminary survey study. Front Psychiatry 2021; 12: 666588. https://doi.org/10.3389/fpsyt.2021.666588.
  21. Peng P, Hao Y, Liu Y, Chen S, Wang Y, Yang Q, et al. The prevalence and risk factors of mental problems in medical students during COVID-19 pandemic: A systematic review and meta-analysis. J Affect Disord 2023; 321: 167-181. https://doi.org/10.1016/j.jad.2022.10.040.
  22. Monrad SU, Wolff M, Kurtz J, Deiorio NM, Sabo R, Stringer JK, et al. What is the association between student well-being and high-stakes examination scores? Med Educ 2021; 55(7): 872-877. https://doi.org/10.1111/medu.14460.
  23. Karataş Y, Khan Z, Bilen Ç, Boz A, Özagil ESG, Abussuutoğlu AB, et al. Traditional and complementary medicine use and beliefs during COVID-19 outbreak: A cross-sectional survey among the general population in Turkey. Adv Integr Med 2021; 8(4): 261-266. https://doi.org/10.1016/j.aimed.2021.09.002.
  24. Perez-Arce F, Angrisani M, Bennett D, Darling J, Kapteyn A, Thomas K. COVID-19 vaccines and mental distress. PLoS One 2021; 16(9): e0256406. https://doi.org/10.1371/journal.pone.0256406.
  25. Alkodaymi MS, Omrani OA, Ashraf N, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin Microbiol Infect 2022; 28(5): 657-666. https://doi.org/10.1016/j.cmi.2022.01.014.
  26. Bobo WV, Grossardt BR, Virani S, St Sauver JL, Boyd CM, Rocca WA. Association of depression and anxiety with the accumulation of chronic conditions. JAMA Netw Open 2022; 5(5): e229817. https://doi.org/10.1001/jamanetworkopen.2022.9817.
  27. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29(2): 147-155. https://doi.org/10.1016/j.genhosppsych.2006.11.005.
  28. Hosseini-Kamkar N, Lowe C, Morton JB. The differential calibration of the HPA axis as a function of trauma versus adversity: A systematic review and p-curve meta-analyses. Neurosci Biobehav Rev 2021; 127: 54-135. https://doi.org/10.1016/j.neubiorev.2021.04.006.
  29. Dunlop BW, Wong A. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions. Prog Neuropsychopharmacol Biol Psychiatry 2019; 89: 361-379. https://doi.org/10.1016/j.pnpbp.2018.10.010.
  30. Masten AS, Lucke CM, Nelson KM, Stallworthy IC. Resilience in development and psychopathology: Multisystem perspectives. Annu Rev Clin Psychol 2021; 17: 521-549. https://doi.org/10.1146/annurev-clinpsy-081219-120307.
  31. Penley JA, Tomaka J, Wiebe JS. The association of coping to physical and psychological health outcomes: A meta-analytic review. J Behav Med 2002; 25(6): 551-603. https://doi.org/10.1023/a:1020641400589.
  32. Hjemdal O, Vogel PA, Solem S, Hagen K, Stiles TC. The relationship between resilience and levels of anxiety, depression, and obsessive-compulsive symptoms in adolescents. Clin Psychol Psychother 2011; 18(4): 314-321. https://doi.org/10.1002/cpp.719.
  33. Pelaccia T, Sibilia J, Fels É, Gauer L, Musanda A, Severac F, et al. And if we had to do it all over again, would we send medical students to the emergency departments during a pandemic? Lessons learned from the COVID-19 outbreak. Intern Emerg Med 2021; 16(7): 1967-1974. https://doi.org/10.1007/s11739-020-02629-0.
  34. Hosseinzadeh Oskouei A, Zamani Zarchi MS, Piryaei M, Yaghubi H, Shams J, Kianimoghadam AS. Suggestions for solving the suicide mystery among Iranian medical residents. Iran J Med Sci 2024; 49(9): 608-609. https://doi.org/10.30476/ijms.2024.102570.3562.
  35. Passi V. Developing resilience throughout the continuum of medical education. Perspect Med Educ 2014; 3(5): 329-331. https://doi.org/10.1007/s40037-014-0140-1.
  36. Wang C, Liu Q, Li H, Liu Y. The path of college students' entrepreneurship education under causal attribution theory from the perspective of entrepreneurial psychology. Front Psychol 2022; 13: 810615. https://doi.org/10.3389/fpsyg.2022.810615.
  37. Fu W, Wang C, Zou L, Guo Y, Lu Z, Yan S, et al. Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan, China. Transl Psychiatry 2020; 10(1): 225. https://doi.org/10.1038/s41398-020-00913-3.
  38. Lim D, Jeong J, Song YM, Cho CH, Yeom JW, Lee T, et al. Accurately predicting mood episodes in mood disorder patients using wearable sleep and circadian rhythm features. NPJ Digit Med 2024; 7(1): 324. https://doi.org/10.1038/s41746-024-01333-z.
  39. Ali AMA, Adam OAM, Salem SEM, Hamad SHI, Ahmed NEM, Ali HMA, et al. Prevalence of physical and mental health problems among internally displaced persons in White Nile state, Sudan 2023: A cross sectional study. BMC Public Health 2024; 24(1): 3448. https://doi.org/10.1186/s12889-024-20972-1.
  40. Cheng P, Wang L, Zhou Y, Ma W, Li W. Exploring the differential effects of psychological resilience and social support in mitigating post-traumatic psychiatric symptoms: Real-world network analysis of front-line rescuers. BJPsych Open 2024; 10(3): e109. https://doi.org/10.1192/bjo.2024.64.
  41. Charles D, Angelone DJ, Jones MC. The Role of coping behaviors and intoxication in trauma symptomology subsequent to sexual victimization. J Child Sex Abus 2023; 32(6): 749-770. https://doi.org/10.1080/10538712.2023.2223585.
  42. Mikutta C, Schmid JJ, Ehlert U. Resilience and post-traumatic stress disorder in the Swiss Alpine Rescue Association. Front Psychiatry 2022; 13: 780498. https://doi.org/10.3389/fpsyt.2022.780498.
  43. Read JP, Griffin MJ, Wardell JD, Ouimette P. Coping, PTSD symptoms, and alcohol involvement in trauma-exposed college students in the first three years of college. Psychol Addict Behav 2014; 28(4): 1052-1064. https://doi.org/10.1037/a0038348.
About the Authors: 

Leyi Fang – Master’s Student, School of Nursing, College of Medicine, Huzhou University, Huzhou, China. https://orcid.org/0009-0001-0818-5826

Received 20 May 2025, Revised 20 October 2025, Accepted 20 November 2025 
© 2025, Russian Open Medical Journal 
Correspondence to Leyi Fang. Address: 759 Erhuandong Rd., Huzhou 313000, Zhejiang Province, China. Phone: +86 18957266066. E-mail: Coldgun9@163.com.

Author(s):